NEW YORK / RankWire.AI / – On Wednesday, U.S. stocks experienced modest gains as long-term Treasury yields declined significantly. The S&P 500 increased by 16.22 points, or 0.21%, to reach 7,707.98, ending a streak of three consecutive sessions of decline. Meanwhile, the Dow Jones Industrial Average rose 119.65 points, or 0.22%, closing at 53,463.05. The Nasdaq Composite added 41.38 points, or 0.16%, finishing at 26,331.09. The drop in government bond yields contributed to a recovery for major indices after several sessions marked by upward pressure on borrowing costs.
Bond prices went up following the U.S. Treasury Department’s announcement of increased liquidity support buybacks for longer-term government debt. Beginning September 9, the maximum purchase amount will rise from $2 billion to at least $4 billion per operation. This change applies to nominal coupon securities within the 10-to-20-year and 20-to-30-year maturity categories. The higher volumes will be maintained through November 4. The department explained that strong demand for high-quality offers supported the decision to expand liquidity operations in these sectors.
Following the announcement, Treasury yields moved downward, reversing part of a recent increase in long-term borrowing costs. The 10-year Treasury yield declined to approximately 4.65%, while the 30-year yield fell to around 5.20%. On Tuesday, the 30-year yield had reached 5.337%, its highest level since 2007. As bond yields and prices move inversely, the increased demand for government debt pushed yields lower. This retreat alleviated some of the pressure that had been caused by the recent selloff in longer-term government bonds.
Healthcare Shares Contribute to Market Gains
The healthcare sector provided additional support during Wednesday’s trading, with several pharmaceutical companies posting significant gains. Moderna shares surged by 177%, while Merck increased 12.6%, following positive results from a Phase 3 melanoma trial. The INTerpath-001 study tested personalized mRNA therapy intismeran autogene in combination with Keytruda after surgical removal of high-risk melanoma. The trial achieved its primary endpoint for recurrence-free survival and also met a secondary goal measuring survival without distant cancer spread.
This rally in healthcare stocks helped offset mixed performance elsewhere, especially within the technology sector. Consumer-related equities also contributed to the positive tone after several major firms reported quarterly earnings during the session. Estée Lauder rose more than 16% following its earnings announcement, adding to gains among consumer stocks. Target and Lowe’s also advanced after releasing their latest financial results. Generally, smaller companies outperformed large-cap indices, with the Russell 2000 gaining approximately 0.5%, reflecting broader market recovery.
Wall Street Ends Three-Day Losing Streak
Wednesday’s gains marked the end of a three-session decline for the Nasdaq, the S&P 500, and the Dow. The rebound followed earlier-week pressure from rising long-term yields that weighed on equities. Despite Wednesday’s positive move, the main indexes still closed the week lower. The S&P 500 is roughly 1% below last Friday’s level. The Dow has dropped about 0.5% for the week, while the Nasdaq remains approximately 1.5% lower.
Looking at the broader 2026 outlook, performance remains optimistic despite the recent weekly dip and bond market pressures. As of Wednesday’s close, the S&P 500 has gained about 12.6% year-to-date. The Dow has increased approximately 11.2%, while the Nasdaq leads with a gain of roughly 13.3%, reflecting its stronger year-to-date performance. Wednesday’s session therefore represented a modest recovery for Wall Street, buoyed by lower Treasury yields and gains in the healthcare sector that lifted all three major U.S. stock indexes.